Tripod Therapeutics is a biopharmaceutical company that specializes in proteasome dynamics and its manipulation for treating illnesses. It was established on the basis of comprehensive scientific research conducted by Nobel Prize Laureate Prof Aaron Ciechanover and his team.

about us


Prof. Aaron Ciechanover

Prof. Aaron Ciechanover
Co-founder, CS

Prof. Ciechanover is the Co-discoverer of the Ubiquitin-proteasome system and the 2004 Nobel Prize laureate in chemistry. He has authored more than 250 publications in the field of protein degradation and served on the Scientific Advisory Boards of numerous companies including Protalix Biotherapeutics, and Biotheryx , Inc. Professor Ciechanover is currently a Distinguished Research Professor at the Rappaport Technion Integrated Cancer Center (R-TICC) of the Rappaport Research Institute and Faculty of Medicine at the Technion-Israel Institute of Technology.


Avishai Levy

Avishai Levy has over 20 years of experience in senior management positions. His past roles include CEO of The Galilee Research Institute, a 300+ employees multidisciplinary applied research Institute, CEO of Proteologics Ltd, a public drug discovery company which among its shareholders were Teva and GSK, and a co-facilitator and board member of Immpact Bio, which develops disruptive CAR-T therapies and among its shareholders are J&J, Takeda Ventures, Orbimed, and Novartis Venture Fund. Mr. Levy’s academic record includes Executive LL.M from Northwestern law school, Chicago IL.


Dr. Ido Livneh
Co-founder, CTO

Dr. Ido Livneh is an MD/Ph.D. with 15 years of research experience studying the ubiquitin-proteasome system at Prof Ciechanover’s lab, where the two have discovered the mechanisms underlying proteasome dynamics and the means to manipulate them against cancer cells. Dr. Livneh has authored over 30 publications. Currently a physician at the Institute of Pathology and Cytology at the Rambam Medical Center, he is an alumnus of the Technion Excellence Program and a recipient of multiple competitive fellowships and Technion President Awards for outstanding achievements. 


Itshak (Tzachi) Chodnik
Director of Finance

Itshak (Tzachi) Chodnik, MBA., BSc.Agr, has over 25 years of experience in finance management and advisory. 
Over the years, he managed and advised in financial projects, raised equity, debt, and M&A valued at over $1B worldwide, and held CFO and Director of Finance positions in Biotech, high-tech, and investment banking companies.